(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are INTERVEST OFF-WARE, ULTIMOVACS, and BERGENBIO.

Financial Asset	Price	Change	Updated (EST)
INTERVEST OFF-WARE (INTO.BR)	20.30	35.7%	2023-10-18 12:20:28
ULTIMOVACS (ULTI.OL)	140.40	25.58%	2023-10-18 12:43:53
BERGENBIO (BGBIO.OL)	0.18	16.19%	2023-10-18 12:24:58
SIEM OFFSHORE (SIOFF.OL)	27.60	7.81%	2023-10-18 12:42:58
CABKA (CABKA.AS)	7.80	7.14%	2023-10-18 12:01:06
ABIONYX PHARMA (ABNX.PA)	1.39	5.46%	2023-10-18 12:44:28
2020 BULKERS (2020.OL)	108.90	4.91%	2023-10-18 12:24:03
POLARIS MEDIA (POL.OL)	56.00	4.67%	2023-10-18 12:42:13
IEP INVEST (IEP.BR)	5.65	4.63%	2023-10-18 12:20:19
VEON (VEON.AS)	0.60	4.56%	2023-10-18 12:04:20

The three biggest losers today are BEAULIEU-AV. CERT, EBUSCO HOLDING, and BARCO.

Financial Asset	Price	Change	Updated (EST)
BEAULIEU-AV. CERT (BEAB.BR)	3.66	-17.19%	2023-10-18 12:04:55
EBUSCO HOLDING (EBUS.AS)	6.50	-15.58%	2023-10-18 12:01:36
BARCO (BAR.BR)	14.46	-14.23%	2023-10-18 12:04:51
AKER HORIZONS (AKH.OL)	4.32	-8.09%	2023-10-18 12:24:24
PETROLIA (PSE.OL)	4.25	-7%	2023-10-18 12:42:04
SALMONES CAMANCHAC (SACAM.OL)	33.00	-6.78%	2023-10-18 12:42:36
PCI BIOTECH HOLD (PCIB.OL)	2.12	-6.42%	2023-10-18 12:42:02
NEXT BIOMETRICS GP (NEXT.OL)	5.40	-6.25%	2023-10-18 12:41:21
HYDROGENPRO (HYPRO.OL)	15.72	-6.21%	2023-10-18 12:40:28
BELYSSE GROUP (BELYS.BR)	0.69	-5.72%	2023-10-18 12:05:02

Winners today

1. INTERVEST OFF-WARE (INTO.BR)

35.7% Price Change

Intervest Offices & Warehouses nv (referred to hereafter as “Intervest”) is a public regulated real estate company (RREC) under Belgian law, founded in 1996, of which the shares have been listed on Euronext Brussels (INTO) since 1999. Intervest invests in logistics real estate in Belgium and The Netherlands and in office buildings in Belgium. Investments are focused on up-to-date buildings and sustainable (re)development projects, located in strategic locations, with an eye on cluster formation and is aimed at first-rate tenants. The logistics segment of the portfolio in Belgium is located on the Antwerp – Brussels – Nivelles, Antwerp – Limburg – Liège, and Antwerp – Ghent – Bruges axes and, in the Netherlands, on the Moerdijk – 's Hertogenbosch – Nijmegen, Rotterdam – Gorinchem – Nijmegen and Bergen-op-Zoom – Eindhoven – Venlo axes. The office segment of the real estate portfolio focuses on the central cities with an important student population of Antwerp, Mechelen, Brussels and Leuven and their surroundings. Intervest distinguishes itself in renting space by going beyond merely renting m². The company goes beyond real estate.

BEL 20 ended the session with INTERVEST OFF-WARE jumping 35.7% to €20.30 on Wednesday while BEL 20 fell 1.56% to €3,462.93.

Earnings Per Share

As for profitability, INTERVEST OFF-WARE has a trailing twelve months EPS of €0.05.

PE Ratio

INTERVEST OFF-WARE has a trailing twelve months price to earnings ratio of 406. Meaning, the purchaser of the share is investing €406 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.85%.

More news about INTERVEST OFF-WARE.

2. ULTIMOVACS (ULTI.OL)

25.58% Price Change

Ultimovacs ASA, a biotech company, develops immunotherapies against cancers. Its lead product candidate is UV1, a peptide-based cancer vaccine that induces a specific T cell response against the universal cancer antigen telomerase. The company was incorporated in 2011 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with ULTIMOVACS jumping 25.58% to €140.40 on Wednesday while Oslo Børs Benchmark Index_GI jumped 0.19% to €1,312.26.

Earnings Per Share

As for profitability, ULTIMOVACS has a trailing twelve months EPS of kr-5.66.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -40.11%.

Yearly Top and Bottom Value

ULTIMOVACS’s stock is valued at kr140.40 at 22:40 EST, under its 52-week high of kr142.60 and way above its 52-week low of kr58.50.

More news about ULTIMOVACS.

3. BERGENBIO (BGBIO.OL)

16.19% Price Change

BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in development of novel medicines to treat immune-evasive, drug resistant, and metastatic cancers; and respiratory diseases. It develops bemcentinib, an oral once-a-day inhibitor of AXL receptor tyrosine kinase, which is in Phase 1b/2a clinical trial to treat non-small cell lung cancer, and Phase 2 clinical trial to treat acute myeloid leukemia and COVID-19. Bemcentinib is also being studied for glioblastoma, 2L lung cancer, melanoma, pancreatic cancer, and mesothelioma. In addition, the company is developing tilvestamab, an anti-AXL function-blocking monoclonal antibody that is in Phase 1b clinical trial for the treatment of ovarian cancer; and mipasetamab uzoptirine, which is in Phase 1 clinical trial for the treatment of solid tumors. It has a collaboration agreement with Merck & Co. for clinical trials. The company was incorporated in 2007 and is based in Bergen, Norway.

Oslo Børs Benchmark Index_GI ended the session with BERGENBIO jumping 16.19% to €0.18 on Wednesday, after two consecutive sessions in a row of gains. Oslo Børs Benchmark Index_GI jumped 0.19% to €1,312.26, following the last session’s downward trend on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, BERGENBIO has a trailing twelve months EPS of kr-1.83.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -179.58%.

Yearly Top and Bottom Value

BERGENBIO’s stock is valued at kr0.18 at 22:40 EST, way below its 52-week high of kr13.03 and way above its 52-week low of kr0.08.

Volatility

BERGENBIO’s last week, last month’s, and last quarter’s current intraday variation average was 3.09%, 1.48%, and 5.24%.

BERGENBIO’s highest amplitude of average volatility was 8.57% (last week), 4.58% (last month), and 5.24% (last quarter).

Volume

Today’s last reported volume for BERGENBIO is 185142000 which is 373.56% above its average volume of 39095200.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BERGENBIO’s stock is considered to be oversold (<=20).

More news about BERGENBIO.

4. SIEM OFFSHORE (SIOFF.OL)

7.81% Price Change

Siem Offshore Inc., together with its subsidiaries, owns and operates offshore support vessels for the offshore energy service industry and offshore renewables market. It operates platform supply vessels (PSVs); offshore subsea construction vessels (OSCVs); anchor-handling tug supply vessels (AHTS vessels); multipurpose field and ROV support vessels; scientific core drilling vessels (SCDVs); well intervention vessels (WIVs); and other vessels, including fast crew, fast supply, and oilspill recovery vessels. The company has a fleet of 28 vessels, which includes six PSVs, four OSCVs, eight AHTS vessels, two WIVs, one SCDV, five smaller Brazilian flagged vessels, and one Canadian flagged vessel comprising an AHTS vessel. It operates in Norway, North Sea, Brazil, Australia, Canada, Northern Pacific Ocean, Southeast Asia, and West Africa. Siem Offshore Inc. was founded in 2005 and is headquartered in Kristiansand, Norway.

Oslo Børs Benchmark Index_GI ended the session with SIEM OFFSHORE rising 7.81% to €27.60 on Wednesday while Oslo Børs Benchmark Index_GI rose 0.19% to €1,312.26.

Earnings Per Share

As for profitability, SIEM OFFSHORE has a trailing twelve months EPS of kr2.98.

PE Ratio

SIEM OFFSHORE has a trailing twelve months price to earnings ratio of 9.26. Meaning, the purchaser of the share is investing kr9.26 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.4%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

SIEM OFFSHORE’s EBITDA is 193.87.

More news about SIEM OFFSHORE.

5. CABKA (CABKA.AS)

7.14% Price Change

Cabka N.V. manufactures and sells pallets and containers made from recycled plastic in Europe and North America. The company sells its recycled plastic products to blue chip clients in the food and beverage, retail, automotive, dairy, meat and poultry, chemical, pharmaceutical, and pooling industries in approximately 80 countries. Cabka N.V. was incorporated in 1994 and is headquartered in Berlin, Germany.

AEX-Index ended the session with CABKA jumping 7.14% to €7.80 on Wednesday, after three successive sessions in a row of losses. AEX-Index dropped 0.98% to €729.57, after two consecutive sessions in a row of gains, on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, CABKA has a trailing twelve months EPS of €-1.15.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -37.67%.

Volatility

CABKA’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.38%, a negative 0.48%, and a positive 3.28%.

CABKA’s highest amplitude of average volatility was 2.26% (last week), 3.97% (last month), and 3.28% (last quarter).

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Aug 17, 2023, the estimated forward annual dividend rate is 0.05 and the estimated forward annual dividend yield is 0.69%.

Volume

Today’s last reported volume for CABKA is 8024 which is 33.57% above its average volume of 6007.

More news about CABKA.

6. ABIONYX PHARMA (ABNX.PA)

5.46% Price Change

ABIONYX Pharma SA, a biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases. The company is developing CER-001, a negatively-charged lipoprotein particle which contains human recombinant apoA-I, the natural high density lipoprotein (HDL) protein, and sphingomyelin and dipalmitoylphosphatidylglycerol natural phospholipids designed to mimicks the structural and functional biological properties of pre-beta HDL for the treatment of post-acute coronary syndrome patients and familial primary hypoalphalipoproteinemia patients; CER-002, a peroxisome proliferator-activated receptor delta specific agonist for the treatment of cardiovascular and metabolic diseases; and CER-209, a drug candidate for the treatment of metabolic diseases in the liver, as well as atherosclerois and non-alcoholic steato-hepatitis. It has a strategic partnership with GTP Biologics and VBI Therapeutics Group for the bioproduction of the bio-HDL in France. The company was formerly known as Cerenis Therapeutics Holding SA and changed its name to ABIONYX Pharma SA in August 2019. ABIONYX Pharma SA was founded in 2005 and is based in Balma, France.

CAC 40 ended the session with ABIONYX PHARMA jumping 5.46% to €1.39 on Wednesday, after two successive sessions in a row of gains. CAC 40 slid 0.91% to €6,965.99, after two successive sessions in a row of gains, on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, ABIONYX PHARMA has a trailing twelve months EPS of €-0.15.

Yearly Top and Bottom Value

ABIONYX PHARMA’s stock is valued at €1.39 at 22:40 EST, way under its 52-week high of €2.49 and way higher than its 52-week low of €1.11.

More news about ABIONYX PHARMA.

7. 2020 BULKERS (2020.OL)

4.91% Price Change

2020 Bulkers Ltd. owns and operates large dry bulk vessels worldwide. It operates eight scrubber fitted 208,000 deadweight tonnage Newcastlemax dry bulk vessels. The company was incorporated in 2017 and is based in Hamilton, Bermuda.

Oslo Børs Benchmark Index_GI ended the session with 2020 BULKERS rising 4.91% to €108.90 on Wednesday, after four sequential sessions in a row of gains. Oslo Børs Benchmark Index_GI jumped 0.19% to €1,312.26, following the last session’s downward trend on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, 2020 BULKERS has a trailing twelve months EPS of kr9.61.

PE Ratio

2020 BULKERS has a trailing twelve months price to earnings ratio of 11.33. Meaning, the purchaser of the share is investing kr11.33 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.64%.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is a negative 83.8% and a negative 76.5%, respectively.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Aug 22, 2023, the estimated forward annual dividend rate is 6.84 and the estimated forward annual dividend yield is 7.15%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, 2020 BULKERS’s stock is considered to be oversold (<=20).

Volatility

2020 BULKERS’s last week, last month’s, and last quarter’s current intraday variation average was 1.00%, 0.52%, and 1.36%.

2020 BULKERS’s highest amplitude of average volatility was 1.00% (last week), 1.64% (last month), and 1.36% (last quarter).

More news about 2020 BULKERS.

8. POLARIS MEDIA (POL.OL)

4.67% Price Change

Polaris Media ASA operates as a digital media company in Norway and Sweden. The company provides digital advertising services. It also prints corporate and external newspapers, including editorial vouchers, advertising vouchers and newspapers, civil prints, and other magazines/vouchers. In addition, the company distributes newspapers, as well as parcels, mails, and food deliveries. The company is headquartered in Trondheim, Norway.

Oslo Børs Benchmark Index_GI ended the session with POLARIS MEDIA rising 4.67% to €56.00 on Wednesday, after two sequential sessions in a row of losses. Oslo Børs Benchmark Index_GI jumped 0.19% to €1,312.26, following the last session’s downward trend on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, POLARIS MEDIA has a trailing twelve months EPS of kr1.78.

PE Ratio

POLARIS MEDIA has a trailing twelve months price to earnings ratio of 31.46. Meaning, the purchaser of the share is investing kr31.46 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.83%.

Yearly Top and Bottom Value

POLARIS MEDIA’s stock is valued at kr56.00 at 22:40 EST, way below its 52-week high of kr64.00 and way above its 52-week low of kr47.20.

More news about POLARIS MEDIA.

9. IEP INVEST (IEP.BR)

4.63% Price Change

Iep Invest, NV is an investment firm specializing in investments in and loans to real estate companies. The firm previously operated as manufacturing group. It was formerly known as Punch International nv and changed its name to Iep Invest, NV in May 2014. Iep Invest, NV was founded in 1982 and is based in Antwerp, Belgium.

BEL 20 ended the session with IEP INVEST jumping 4.63% to €5.65 on Wednesday while BEL 20 fell 1.56% to €3,462.93.

Earnings Per Share

As for profitability, IEP INVEST has a trailing twelve months EPS of €-0.22.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -2.4%.

More news about IEP INVEST.

10. VEON (VEON.AS)

4.56% Price Change

VEON Ltd., together with its subsidiaries, provides mobile and fixed-line telecommunications services It offers voice, data, and other telecommunication services through a range of wireless, fixed, and broadband internet services. The company provides value-added services, including short messages, multimedia messages, caller number identification, call waiting, data transmission, mobile internet, downloadable content, mobile finance, machine-to-machine, and other services; national and international roaming services; wireless internet access; internet-TV services; digital and systems integration services; mobile financial services; and mobile bundles and call completion services. It offers value-added services for corporations, operators, and consumers, as well as sells equipment, infrastructure, and accessories. The company provides its services under the Beeline, Kyicvcstar, Jazz, Djezzy, and banglalink brands in Russia, Pakistan, Algeria, Uzbekistan, Ukraine, Bangladesh, Kazakhstan, Kyrgyzstan, and Georgia. The company was formerly known as VimpelCom Ltd. and changed its name to VEON Ltd. in March 2017. VEON Ltd. was founded in 1992 and is headquartered in Amsterdam, the Netherlands.

AEX-Index ended the session with VEON jumping 4.56% to €0.60 on Wednesday while AEX-Index dropped 0.98% to €729.57.

Earnings Per Share

As for profitability, VEON has a trailing twelve months EPS of €0.26.

PE Ratio

VEON has a trailing twelve months price to earnings ratio of 2.29. Meaning, the purchaser of the share is investing €2.29 for every euro of annual earnings.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, VEON’s stock is considered to be overbought (>=80).

More news about VEON.

Losers Today

1. BEAULIEU-AV. CERT (BEAB.BR)

-17.19% Price Change

Immo-Beaulieu NV owns and operates real estate properties. The company is based in Brussels, Belgium. Immo-Beaulieu NV operates as a subsidiary of KBC Bank NV.

BEL 20 ended the session with BEAULIEU-AV. CERT dropping 17.19% to €3.66 on Wednesday while BEL 20 dropped 1.56% to €3,462.93.

Volume

Today’s last reported volume for BEAULIEU-AV. CERT is 73 which is 46% above its average volume of 50.

More news about BEAULIEU-AV. CERT.

2. EBUSCO HOLDING (EBUS.AS)

-15.58% Price Change

Ebusco Holding N.V., together with its subsidiaries, develops, manufactures, and distributes zero emission buses, batteries, and charging systems in the Netherlands, Belgium, France, Germany, Norway, Switzerland, and Denmark. It also sells ancillary products and services; and provides electric vehicle ecosystem repair and maintenance services. Ebusco Holding N.V. was founded in 2010 and is headquartered in Deurne, the Netherlands.

AEX-Index ended the session with EBUSCO HOLDING sliding 15.58% to €6.50 on Wednesday, after five sequential sessions in a row of gains. AEX-Index dropped 0.98% to €729.57, after two successive sessions in a row of gains, on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, EBUSCO HOLDING has a trailing twelve months EPS of €-1.11.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -20.25%.

More news about EBUSCO HOLDING.

3. BARCO (BAR.BR)

-14.23% Price Change

Barco NV, together with its subsidiaries, develops visualization solutions for the entertainment, enterprise, and healthcare markets in Belgium and internationally. The company operates through three divisions: Entertainment, Enterprise, and Healthcare. The company offers medical displays, including radiology, dental, breast imaging, surgical, clinical review, and custom medical displays; rear-projection, and LED and LCD video walls, as well as video wall controllers; wireless conferencing and presentation systems; and medical platforms, such as skin imaging, digital operation, and medical advice equipment. It also offers projection products, such as cinema, home cinema, installation, post production, rental, simulation, and virtual reality; virtual and hybrid classrooms comprising weconnect, a virtual classroom; virtual reality system that provides power walls, canvas, and caves; control room software, such as secureStream, OpSpace, and transForm N CMS; image processing products, including presentation switchers, controllers, scalers, and cards; and support, maintenance, training, and professional services. Barco NV was founded in 1934 and is headquartered in Kortrijk, Belgium.

BEL 20 ended the session with BARCO dropping 14.23% to €14.46 on Wednesday, after five consecutive sessions in a row of losses. BEL 20 dropped 1.56% to €3,462.93, following the last session’s downward trend on what was an all-around bearish trend trading session today.

Earnings Per Share

As for profitability, BARCO has a trailing twelve months EPS of €0.94.

PE Ratio

BARCO has a trailing twelve months price to earnings ratio of 15.38. Meaning, the purchaser of the share is investing €15.38 for every euro of annual earnings.

Volume

Today’s last reported volume for BARCO is 812444 which is 475.68% above its average volume of 141126.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BARCO’s stock is considered to be overbought (>=80).

Volatility

BARCO’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.25%, a negative 0.69%, and a positive 1.37%.

BARCO’s highest amplitude of average volatility was 1.25% (last week), 1.01% (last month), and 1.37% (last quarter).

More news about BARCO.

4. AKER HORIZONS (AKH.OL)

-8.09% Price Change

Aker Horizons ASA, through its subsidiaries, develops and invests in a portfolio of companies in the renewable energy and green technology comprising private and public companies worldwide. It sources, develops, structures, builds, and operates wind and solar power assets; and develops, builds, owns, and operates clean hydrogen production at industrial scale. The company also provides products, technology, and solutions within the field of carbon capture, utilization, and storage. In addition, it offers products and services to the hydropower industry; designs and delivers superconducting systems; and produces silicon materials. The company was incorporated in 2020 and is headquartered in Lysaker, Norway. Aker Horizons ASA is a subsidiary of Aker Capital AS.

Oslo Børs Benchmark Index_GI ended the session with AKER HORIZONS dropping 8.09% to €4.32 on Wednesday, after two successive sessions in a row of gains. Oslo Børs Benchmark Index_GI jumped 0.19% to €1,312.26, following the last session’s downward trend on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, AKER HORIZONS has a trailing twelve months EPS of kr-10.3.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -81.14%.

Volume

Today’s last reported volume for AKER HORIZONS is 6548050 which is 53.85% above its average volume of 4255920.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AKER HORIZONS’s stock is considered to be oversold (<=20).

Volatility

AKER HORIZONS’s last week, last month’s, and last quarter’s current intraday variation average was 2.94%, 0.35%, and 3.41%.

AKER HORIZONS’s highest amplitude of average volatility was 3.59% (last week), 4.05% (last month), and 3.41% (last quarter).

More news about AKER HORIZONS.

5. PETROLIA (PSE.OL)

-7% Price Change

Petrolia SE, together with its subsidiaries, sells and rents energy service equipment to energy industry in Norway, rest of Europe, Asia, and Australia. It operates through two segments, Energy and Energy Service. The company engages in the exploration and production of oil and gas, as well as produces hydrogen and ammonia. It also offers drill pipes, test strings and tubing, and other equipment, as well as casing, handling, and auxiliary tools; and equipment inspection and maintenance services. In addition, the company offers casing and tubing running, drilling, and make and brake services. It serves energy companies, drilling contractors, and energy service companies. The company was formerly known as Petrolia E&P Holdings SE and changed its name to Petrolia SE in January 2013. Petrolia SE was founded in 1997 and is based in Limassol, Cyprus.

Oslo Børs Benchmark Index_GI ended the session with PETROLIA sliding 7% to €4.25 on Wednesday while Oslo Børs Benchmark Index_GI rose 0.19% to €1,312.26.

Earnings Per Share

As for profitability, PETROLIA has a trailing twelve months EPS of kr0.05.

PE Ratio

PETROLIA has a trailing twelve months price to earnings ratio of 85. Meaning, the purchaser of the share is investing kr85 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.94%.

Moving Average

PETROLIA’s worth is above its 50-day moving average of kr4.12 and higher than its 200-day moving average of kr4.08.

More news about PETROLIA.

6. SALMONES CAMANCHAC (SACAM.OL)

-6.78% Price Change

Salmones Camanchaca S.A. engages in the salmon farming business in Chile. The company offers Atlantic and Coho salmon products in various formats, such as whole, fillet, portion, and other products including bits and pieces, harasu, and scrape meat. It also exports its products. The company was incorporated in 2009 and is based in Puerto Montt, Chile. Salmones Camanchaca S.A. is a subsidiary of Compañía Pesquera Camanchaca S.A.

Oslo Børs Benchmark Index_GI ended the session with SALMONES CAMANCHAC falling 6.78% to €33.00 on Wednesday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI jumped 0.19% to €1,312.26, following the last session’s downward trend on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, SALMONES CAMANCHAC has a trailing twelve months EPS of kr4.89.

PE Ratio

SALMONES CAMANCHAC has a trailing twelve months price to earnings ratio of 6.75. Meaning, the purchaser of the share is investing kr6.75 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.89%.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Apr 28, 2023, the estimated forward annual dividend rate is 3.56 and the estimated forward annual dividend yield is 9.53%.

More news about SALMONES CAMANCHAC.

7. PCI BIOTECH HOLD (PCIB.OL)

-6.42% Price Change

PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company develops anticancer paradigms, including fimaCHEM, a chemotherapeutics for treatment of cancer; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is in pre-clinical study; and fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study. It also offers Amphinex, a photosensitiser fimaporfin. The company has collaborative research programs with Olix Pharmaceuticals, Aposense, IMV Immunovaccine, MDimune, eTheRNA, and Immunicum. PCI Biotech Holding ASA was incorporated in 2007 and is based in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with PCI BIOTECH HOLD dropping 6.42% to €2.12 on Wednesday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI jumped 0.19% to €1,312.26, following the last session’s downward trend on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, PCI BIOTECH HOLD has a trailing twelve months EPS of kr-1.68.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -47.54%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

PCI BIOTECH HOLD’s EBITDA is -4.54.

Revenue Growth

Year-on-year quarterly revenue growth declined by 84.4%, now sitting on 2.79M for the twelve trailing months.

More news about PCI BIOTECH HOLD.

8. NEXT BIOMETRICS GP (NEXT.OL)

-6.25% Price Change

NEXT Biometrics Group ASA, through its subsidiaries, engages in the research, development, manufacture, and commercialization of fingerprint technology and products in Asia. The company offers fingerprint sensor modules and readers, flexible biometric subassemblies, and face recognition software, as well as software and hardware development kits for USB and SPI modules. Its products are used in point of sales terminals, smart card, government ID, access control, internet of things, and notebook applications. The company sells its sensors to distributors of electronic components. NEXT Biometrics Group ASA was incorporated in 2001 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with NEXT BIOMETRICS GP sliding 6.25% to €5.40 on Wednesday, after four sequential sessions in a row of losses. Oslo Børs Benchmark Index_GI rose 0.19% to €1,312.26, following the last session’s downward trend on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, NEXT BIOMETRICS GP has a trailing twelve months EPS of kr-0.6.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -59.74%.

Yearly Top and Bottom Value

NEXT BIOMETRICS GP’s stock is valued at kr5.40 at 22:40 EST, way under its 52-week high of kr6.70 and way higher than its 52-week low of kr3.70.

Earnings Before Interest, Taxes, Depreciation, and Amortization

NEXT BIOMETRICS GP’s EBITDA is -26.64.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, NEXT BIOMETRICS GP’s stock is considered to be overbought (>=80).

Revenue Growth

Year-on-year quarterly revenue growth declined by 35.7%, now sitting on 41.39M for the twelve trailing months.

More news about NEXT BIOMETRICS GP.

9. HYDROGENPRO (HYPRO.OL)

-6.21% Price Change

HydrogenPro ASA designs and supplies customized hydrogen plants. It provides high-pressure alkaline electrolysers. The company was incorporated in 2013 and is headquartered in Porsgrunn, Norway.

Oslo Børs Benchmark Index_GI ended the session with HYDROGENPRO sliding 6.21% to €15.72 on Wednesday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI jumped 0.19% to €1,312.26, following the last session’s downward trend on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, HYDROGENPRO has a trailing twelve months EPS of kr-0.75.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -9.4%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 1662.6%, now sitting on 260.32M for the twelve trailing months.

Yearly Top and Bottom Value

HYDROGENPRO’s stock is valued at kr15.72 at 22:40 EST, below its 52-week low of kr17.02.

More news about HYDROGENPRO.

10. BELYSSE GROUP (BELYS.BR)

-5.72% Price Change

Belysse Group NV produces and sells textile floor coverings for commercial and residential applications in Europe, North America, and internationally. The company designs, manufactures, and distributes broadloom carpets and modular carpet tiles primarily for offices and public projects. It commercializes its products under the Bentley, modulyss, arc edition, and ITC brands. The company was formerly known as Balta Group NV and changed its name to Belysse Group NV in October 2022. Belysse Group NV was founded in 1964 and is headquartered in Waregem, Belgium. Belysse Group NV is a subsidiary of LSF9 Belysse Holdco S.à r.l.

BEL 20 ended the session with BELYSSE GROUP dropping 5.72% to €0.69 on Wednesday, following the last session’s upward trend. BEL 20 fell 1.56% to €3,462.93, following the last session’s downward trend on what was an all-around bearish trend exchanging session today.

Earnings Per Share

As for profitability, BELYSSE GROUP has a trailing twelve months EPS of €-0.45.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BELYSSE GROUP’s stock is considered to be oversold (<=20).

More news about BELYSSE GROUP.

Stay up to date with our winners and losers daily report